Evaluation of Hepatic Glutathione Transferase Mu 1 and Theta 1 Activities in Humans and Mice Using Genotype Information

被引:10
作者
Arakawa, Shingo [1 ]
Fujimoto, Kazunori [1 ]
Kato, Ayako [2 ]
Endo, Seiko [2 ]
Fukahori, Aiko [2 ]
Shinagawa, Akira [2 ]
Fischer, Thomas [3 ]
Mueller, Juergen [3 ]
Takasaki, Wataru [4 ]
机构
[1] Daiichi Sankyo Co Ltd, Med Safety Res Labs, Shizuoka 4370065, Japan
[2] Daiichi Sankyo Co Ltd, Translat Med & Clin Pharmacol Dept, Shinagawa Ku, Tokyo, Japan
[3] Daiichi Sankyo Europe GmbH, Metab Dept, Martinsried, Germany
[4] Daiichi Sankyo Inc, Edison, NJ USA
关键词
S-TRANSFERASE; NULL GENOTYPES; KNOCKOUT MICE; LIVER; RISK; ACTIVATION; EXPRESSION; GSTT1; M1; GLUTATHIONE-S-TRANSFERASE-T1;
D O I
10.1124/dmd.111.042911
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We investigated the impact of glutathione transferases Mu 1 (GSTM1)- and glutathione transferase Theta 1 (GSTT1)-null genotypes on hepatic GST activities in humans and compared the results with those of Gstm1- and Gstt1-null mice. In liver with GSTM1/Gstm1-null genotype, GST activity toward p-nitrobenzyl chloride (NBC) was significantly decreased in both humans and mice. In addition, in liver with GSTT1/Gstt1-null genotype, GST activity toward dichloromethane (DCM) was significantly decreased in both humans and mice. Therefore, null genotypes of GSTM1/Gstm1 and GSTT1/Gstt1 are considered to decrease hepatic GST activities toward NBC and DCM, respectively, in both humans and mice. This observation shows the functional similarity between humans and mice for GSTM1 and GSTT1 toward some substrates. In the case of NBC and DCM, Gst-null mice would be relevant models for humans with GST-null genotype. In addition, decreases in GST activities toward 1,2-dichloro-4-nitrobenzene, trans-4-phenyl-3-buten-2-one, and 1-chloro-2,4,-dinitrobenzene were observed in Gstm1-null mice, and a decrease in GST activity toward 1,2-epoxy-3-(p-nitrophenoxy) propane was observed in Gstt1-null mice. However, an impact of GST-null genotypes on GST activities toward these substrates was not observed in humans. In the case of these mouse-specific substrates, Gst-null mice may be relevant models for humans regardless of GST genotype, because GST activities, which are higher in wild-type mice than in humans, were eliminated in Gst-null mice. This study shows that comparison of hepatic GST activities between humans and mice using genotype information would be valuable in using Gst-null mice as human models.
引用
收藏
页码:497 / 503
页数:7
相关论文
共 39 条
  • [1] Pharmacogenomics in Drug Induced Liver Injury
    Andrade, Raul J.
    Agundez, Jose A. G.
    Isabel Lucena, M.
    Martinez, Carmen
    Cueto, Raquel
    Garcia-Martin, Elena
    [J]. CURRENT DRUG METABOLISM, 2009, 10 (09) : 956 - 970
  • [2] Methemoglobinemia Induced by 1,2-Dichloro-4-nitrobenzene in Mice with a Disrupted Glutathione S-Transferase Mu 1 Gene
    Arakawa, Shingo
    Maejima, Takanori
    Kiyosawa, Naoki
    Yamaguchi, Takashi
    Shibaya, Yukari
    Aida, Yoshie
    Kawai, Ryota
    Fujimoto, Kazunori
    Manabe, Sunao
    Takasaki, Wataru
    [J]. DRUG METABOLISM AND DISPOSITION, 2010, 38 (09) : 1545 - 1552
  • [3] Glutathione-S-transferase-omega [MMA(V) reductase] knockout mice:: Enzyme and arsenic species concentrations in tissues after arsenate administration
    Chowdhury, Uttam K.
    Zakharyan, Robert A.
    Hemandez, Alba
    Avram, Mihaela D.
    Kopplin, Michael J.
    Aposhian, H. Vasken
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2006, 216 (03) : 446 - 457
  • [4] Physiological role of mGSTA4-4, a glutathione S-transferase metabolizing 4-hydroxynonenal:: generation and analysis of mGsta4 null mouse
    Engle, MR
    Singh, SP
    Czernik, PJ
    Gadd, D
    Montague, DC
    Ceci, JD
    Yang, YS
    Awasthi, S
    Awasthi, YC
    Zimniak, P
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 194 (03) : 296 - 308
  • [5] Maleylacetoacetate isomerase (MAAI/GSTZ)-deficient mice reveal a glutathione-dependent nonenzymatic bypass in tyrosine catabolism
    Fernández-Cañón, JM
    Baetscher, MW
    Finegold, M
    Burlingame, T
    Gibson, KM
    Grompe, M
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (13) : 4943 - 4951
  • [6] Generation and functional characterization of mice with a disrupted Glutathione S-transferase, theta 1 gene
    Fujimoto, Kazunori
    Arakawa, Shingo
    Watanabe, Toshiyuki
    Yasumo, Hiroaki
    Ando, Yosuke
    Takasaki, Wataru
    Manabe, Sunao
    Yamoto, Takashi
    Oda, Sen-Ichi
    [J]. DRUG METABOLISM AND DISPOSITION, 2007, 35 (12) : 2196 - 2202
  • [7] Characterization of phenotypes in Gstm1-null mice by cytosolic and in vivo metabolic studies using 1,2-dichloro-4-nitrobenzene
    Fujimoto, Kazunori
    Arakawa, Shingo
    Shibaya, Yukari
    Miida, Hiroaki
    Ando, Yosuke
    Yasumo, Hiroaki
    Hara, Ayako
    Uchiyama, Minoru
    Iwabuchi, Haruo
    Takasaki, Wataru
    Manabe, Sunao
    Yamoto, Takashi
    [J]. DRUG METABOLISM AND DISPOSITION, 2006, 34 (09) : 1495 - 1501
  • [8] Glutathione-S-transferase (GST) M1 null genotype and combined GSTM1 and GSTT1 null genotypes are risk factors for increased serum γ-glutamyltransferase in valproic acid-treated patients
    Fukushima, Yumi
    Seo, Takayuki
    Hashimoto, Nami
    Higa, Yoko
    Ishitsu, Takateru
    Nakagawa, Kazuko
    [J]. CLINICA CHIMICA ACTA, 2008, 389 (1-2) : 98 - 102
  • [9] Activation and detoxication of aflatoxin B1
    Guengerich, FP
    Johnson, WW
    Shimada, T
    Ueng, YF
    Yamazaki, H
    Langouët, S
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1998, 402 (1-2) : 121 - 128
  • [10] HABIG WH, 1974, J BIOL CHEM, V249, P7130